Real‐life study on the pharmacokinetic of remdesivir in ICU patients admitted for severe COVID‐19 pneumonia

Remdesivir is one of the most encouraging treatments against SARS‐CoV‐2 infection. After intravenous infusion, RDV is rapidly metabolized (t (1/2) = 1 h) within the cells to its active adenosine triphosphate analogue form (GS‐443902) and then it can be found in plasma in its nucleoside analogue form...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Br J Clin Pharmacol
Egile Nagusiak: Corcione, Silvia, De Nicolò, Amedeo, Montrucchio, Giorgia, Scabini, Silvia, Avataneo, Valeria, Bonetto, Chiara, Mornese Pinna, Simone, Cusato, Jessica, Canta, Francesca, Urbino, Rosario, Di Perri, Giovanni, Brazzi, Luca, De Rosa, Francesco Giuseppe, D'Avolio, Antonio
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2021
Gaiak:
Short Reports
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8239594/
https://ncbi.nlm.nih.gov/pubmed/33990984
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.14895
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak